Dr. Aroonsiri Howell Provides Perspective to NBC News on FDA’s Approval of Drug for Alzheimer’s Disease

Aroonsiri Howell, MD, MPH, Assistant Professor of Medicine at the Lewis Katz School of Medicine at Temple University, provided perspective to NBC News about the U.S. Food and Drug Administration’s (FDA) approval of aducanumab, or Aduhelm, for Alzheimer’s disease. MSN.com picked up the NBC News piece.